| Sanofi-Aventis (Suisse) SA - VaxigripTetra, Suspension pour injection dans une seringue pré-remplie | | 66427 | | 03 | | VaxigripTetra | | Suspension pour injection dans une seringue pré-remplie | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 07.08.2019 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus souche A/Brisbane/02/2018 (H1N1)-pdm09: reassortant virus IVR-190 derived from A/Brisbane/02/2018) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Kansas/14/2007 (H3N2)-like: reassortant virus NYMC X-327 derived from A/Kansas/14/2017) 15 µg, haemagglutininum influenzae B (Virus souche B/Colorado/06/2017 (Victoria lineage)-like: reassortant virus NYMC BX-69A derived from B/Maryland/15/2016) 15 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum. | | Packungsbestandteile | | Active Agent | Dose |
|---|
| Influenza-haemagglutinin | 60 mcg |
| | BAG: Active Agent | Dose |
|---|
| Influenza-haemagglutinin | 60 mcg |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
